Skip to content

The Reliability and Validity of Turkish Version of ''The Dyspnea-ALS-Scale (DALS-15)

The Reliability and Validity of Turkish Version of ''The Dyspnea-ALS-Scale (DALS-15)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04305639
Enrollment
52
Registered
2020-03-12
Start date
2020-09-01
Completion date
2021-04-08
Last updated
2021-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amyotrophic Lateral Sclerosis, Dyspnea

Brief summary

The Dyspnea-ALS-Scale (DALS-15) is a uni-dimensional scale to measure dyspnea in patients with Amyotrophic Lateral Sclerosis. It can be easily and rapidly applied. The aim of this study is to investigate reliability and validity of Turkish version of the DALS-15.

Interventions

None listed

Sponsors

Istanbul University - Cerrahpasa
CollaboratorOTHER
Istanbul University
CollaboratorOTHER
Istanbul Medeniyet University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age of 18 or above * Dyspnea on exertion, dyspnea at rest, or orthopnea without evidence of pulmonary or cardiac causes of dyspnea

Exclusion criteria

* Severe cognitive dysfunction

Design outcomes

Primary

MeasureTime frameDescription
The Dyspnea-ALS-Scale (DALS-15)10 minutesThe scale is used to measure dyspnea in ALS patients

Secondary

MeasureTime frameDescription
Modified Borg Scale10 minutesA 10 point Modified Borg Scale is used to assess dyspnea in supine and standing positions.
Revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R)15 minutesIt is used to assess functional stats in ALS patients. This study particularly focus on pulmonary functions and dyspnea subscale of the scale.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026